Task: Answer the multiple choice question.
Query: Which compound exhibits a -13.810% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) O=C(CCCn1cnc([N+](=O)[O-])n1)Nc1ccc(F)c(Cl)c1
b.) COc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12
c.) O=C(CSc1nc(-c2ccco2)cc(C(F)(F)F)n1)N1CCN(Cc2ccccc2)CC1
d.) O=C(NCCS(=O)(=O)NCc1ccc2c(c1)OCO2)c1ccccc1
Answer: b. COc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12
COc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12
5-(2-methoxyphenyl)-4-(1-methyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidine